A Case of Repetitive Intrapleural Cancer Chemotherapy Using
INFUSE-A-PORT® for Malignant Mesothelioma

A 57-year-old man was diagnosed as having malignant pleural mesothelioma. We placed an implantable reservoir (INFUSE-A-PORT®) into his pleural cavity to administer repetitive intrapleural chemotherapy. We administered intrapleural chemotherapy 7 times over a period of 10 months. The progression of the disease was very gradual; he could continue working during this time. INFUSE-A-PORT® may be useful for repetitive intrapleural chemotherapy in outpatient treatment of malignant mesothelioma.

Malignant mesothelioma - Intrapleural chemotherapy - INFUSE-A-PORT®

References

• 1 Sugarbaker D J, Norberto J J, Bueno R. Current Therapy for Mesothelioma.  Cancer Control. 1997;  4 ((4)) 326-334
• 2 Butchart E. Contemporary management of malignant pleural mesothelioma.  Oncologist. 1999;  4 ((6)) 488-500
• 3 Sugarbaker D J, Garcia J P, Richards W G. et al . Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.  Ann Surg. 1996;  224 ((3)) 288-294
• 4 Ratto G B, Civalleri D, Esposito M. et al . Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.  J Thorac Cardiovasc Surg. 1999;  117 ((4)) 759-765
• 5 Putnam J B , Light R W, Rodriguez R M. et al . A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions.  Cancer. 1999;  86 ((10)) 1992-1999

Received for Publication: November 23, 2000